0001209191-13-055954.txt : 20131209 0001209191-13-055954.hdr.sgml : 20131209 20131209175125 ACCESSION NUMBER: 0001209191-13-055954 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131205 FILED AS OF DATE: 20131209 DATE AS OF CHANGE: 20131209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biota Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000072444 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 591212264 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100 CITY: ALPHARETTA STATE: 2Q ZIP: 30009 BUSINESS PHONE: 301-770-3099 MAIL ADDRESS: STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100 CITY: ALPHARETTA STATE: 2Q ZIP: 30009 FORMER COMPANY: FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS DATE OF NAME CHANGE: 20100719 FORMER COMPANY: FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS DATE OF NAME CHANGE: 20020304 FORMER COMPANY: FORMER CONFORMED NAME: NABI /DE/ DATE OF NAME CHANGE: 19960405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Azzarello Peter CENTRAL INDEX KEY: 0001591980 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35285 FILM NUMBER: 131266537 MAIL ADDRESS: STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100 CITY: ALPHARETTA STATE: GA ZIP: 30009 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-12-05 0 0000072444 Biota Pharmaceuticals, Inc. BOTA 0001591980 Azzarello Peter 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA GA 30009 0 1 0 0 Chief Accounting Officer Stock Option (Right to Buy) 4.13 2013-12-05 4 A 0 17500 0.00 A 2023-12-05 Common Stock 17500 17500 D Market Stock Units 2013-12-05 4 A 0 4375 0.00 A Common Stock 4375 4375 D This option is a performance based option that will be 100% vested and exercisable upon hitting the primary endpoint for the Issuer's Phase 2 IGLOO trial on or before June 30, 2015, as determined by the Issuer's Compensation Committee in its sole discretion. Each Market Stock Unit (MSU) represents a right to receive up to 2.5 shares of the Issuer's common stock. The vesting amount will be determined based on the twenty day trailing average stock price of the Issuer's common stock measured as of the last day of the performance period beginning on December 5, 2013 and ending on January 1, 2017. Unless earlier forfeited under the terms of the MSU or accelerated upon a change of control transaction, each MSU vests and converts into no more than 2.5 shares of the Issuer's common stock on January 1, 2017. /s/ Peter Azzarello 2013-12-09